# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Guggenheim analyst Evan Wang upgrades Invivyd (NASDAQ:IVVD) from Neutral to Buy and announces $9 price target.
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.